XL-820

· Exelixis

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XL-820, covering 2013-06-07 to 2013-06-07. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study of XL820 in Adults With Advanced GIST Resistant to Imatinib and/or Sunitinib [Phase 2]